Surgimab

Near-infrared fluorescent antibody conjugates as in vivo diagnostic agents for cancer

placeMontpellier, Occitanie, France calendar_todayFounded 2011 groups4 employees language surgimab.com

Social engagement

Social engagement: 1K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Private equity125%
Bank & private debt125%
Other / undisclosed250%

Recent activity

22 Sep 2025
Product launch
SGM-101 website
Coming soon